In this study, GoDARTS data were analysed to assess the effect of OCT1 (also known as SLC22A1) genotype and the use of OCT1-inhibiting drugs on the incidence of metformin intolerance in a large population of patients with type 2 diabetes. This evidence concerns the gene SLC22A1 and type 2 diabetes mellitus.